Literature DB >> 5080415

Coproporphyrin I and 3 excretion in bile and urine.

N Kaplowitz, N Javitt, A Kappas.   

Abstract

The excretion of coproporphyrin isomers I and III was studied in the rat. Both isomers were found to bind equally to rat plasma and liver cytosol in vitro and to disappear from plasma at equal rates after single injections in vivo. During equimolar infusions of isomers into bile fistula animals, both the I and III isomers were excreted in bile in a concentration ratio of 2:1, respectively. Pretreatment of animals with ethinylestradiol or simultaneous infusions of phenoldibromophthalein disulfonate caused a reduction in total hepatic excretion with no change in the 2:1 ratio in bile. As hepatic excretion fell, excretion of both isomers in urine rose, with an increase in the proportion of the I isomer. The findings mimic those reported to occur in man and can be explained by inhibition of a common carrier which requires a stereospecific configuration that statistically favors the hepatic transport of the symmetrical coproporphyrin I isomer.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5080415      PMCID: PMC292439          DOI: 10.1172/JCI107113

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  Separation of the coproporphyrin isomers I and III by thin layer chromatography.

Authors:  J JENSEN
Journal:  J Chromatogr       Date:  1963-02

2.  An analysis of the porphyrins of normal and cirrhotic human liver and normal bile.

Authors:  M A Aziz; C J Watson
Journal:  Clin Chim Acta       Date:  1969-12       Impact factor: 3.786

3.  Urinary excretion of coproporphyrin isomers 1 and 3 and delta-aminolaevulic acid in normal pregnancy and obstetric hepatosis.

Authors:  P Koskelo; I Toivonen
Journal:  Acta Obstet Gynecol Scand       Date:  1968       Impact factor: 3.636

4.  Detection of the heterozygous state in bovine porphyria: analysis of urinary coproporphyrin isomers.

Authors:  W E Moore; B D Stephenson; A S Anderson; S Schwartz
Journal:  Proc Soc Exp Biol Med       Date:  1970-09

5.  Urinary excretion of porphyrin precursors and coproporphyrin in healthy females on oral contraceptives.

Authors:  P Koskelo; A Eisalo; I Toivonen
Journal:  Br Med J       Date:  1966-03-12

6.  Urinary coproporphyrin isomer distribution in the Dubin-Johnson syndrome.

Authors:  P Koskelo; I Toivonen; H Adlercreutz
Journal:  Clin Chem       Date:  1967-11       Impact factor: 8.327

7.  Separation of urinary coproporphyrin isomers 1 and 3 by thin-layer chromatography. Studies in healthy subjects and patients with myocardial infarction.

Authors:  P Koskelo; I Toivonen
Journal:  Scand J Clin Lab Invest       Date:  1966       Impact factor: 1.713

8.  Ether-soluble porphyrins in bile, meconium and urine: a new appraisal by microscale counter-current analysis.

Authors:  J M French; E Thonger
Journal:  Clin Sci       Date:  1966-12       Impact factor: 6.124

9.  Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions.

Authors:  A J Levi; Z Gatmaitan; I M Arias
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

10.  Effect of sodium taurolithocholate on bile flow and bile acid exeretion.

Authors:  N B Javitt; S Emerman
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

View more
  11 in total

1.  Hereditary coproporphyria: comparison of molecular and biochemical investigations in a large family.

Authors:  K R Allen; S D Whatley; T J Degg; J H Barth
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  [Renal and enteral elimination of coproporphyrin isomers in Rotor's syndrome. A family study].

Authors:  H Kellner; W G Zoller; K Jacob; H S Füessl
Journal:  Klin Wochenschr       Date:  1988-10-03

3.  The liver excretes large amounts of heme into bile when heme oxygenase is inhibited competitively by Sn-protoporphyrin.

Authors:  A Kappas; C S Simionatto; G S Drummond; S Sassa; K E Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

Review 4.  [Hepatic porphyrias and alcohol].

Authors:  M O Doss; A Kühnel; U Gross; I Sieg
Journal:  Med Klin (Munich)       Date:  1999-06-15

5.  Clinical Investigation of Coproporphyrins as Sensitive Biomarkers to Predict Mild to Strong OATP1B-Mediated Drug-Drug Interactions.

Authors:  Annett Kunze; Emmanuel Njumbe Ediage; Lieve Dillen; Mario Monshouwer; Jan Snoeys
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447

Review 6.  Environmental chemical exposures and disturbances of heme synthesis.

Authors:  W E Daniell; H L Stockbridge; R F Labbe; J S Woods; K E Anderson; D M Bissell; J R Bloomer; R D Ellefson; M R Moore; C A Pierach; W E Schreiber; A Tefferi; G M Franklin
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

7.  Urinary elimination of coproporphyrins is dependent on ABCC2 polymorphisms and represents a potential biomarker of MRP2 activity in humans.

Authors:  Isabelle Benz-de Bretagne; Renaud Respaud; Patrick Vourc'h; Jean-Michel Halimi; Agnès Caille; Jean-Sébastien Hulot; Christian R Andres; Chantal Le Guellec
Journal:  J Biomed Biotechnol       Date:  2011-03-14

8.  The pharmacokinetics of oral trazpiroben (TAK-906) after organic anion transporting polypeptide 1B1/1B3 inhibition: A phase I, randomized study.

Authors:  Jatinder K Mukker; George Dukes; Max Tolkoff; Lisi Wang; Cristina Almansa; Susanna Y Huh; Mitsuhiro Nishihara; Diane Ramsden; Chunlin Chen
Journal:  Clin Transl Sci       Date:  2022-05-05       Impact factor: 4.438

9.  Endogenous Coproporphyrin I and III are Altered in Multidrug Resistance-Associated Protein 2-Deficient (TR-) Rats.

Authors:  Jacqueline Bezençon; Chitra Saran; Janine Hussner; James J Beaudoin; Yueping Zhang; Hong Shen; John K Fallon; Philip C Smith; Henriette E Meyer Zu Schwabedissen; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2020-10-13       Impact factor: 3.534

Review 10.  Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation.

Authors:  Yang Li; Zahra Talebi; Xihui Chen; Alex Sparreboom; Shuiying Hu
Journal:  Molecules       Date:  2021-09-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.